As of 2025-05-24, the Relative Valuation of Dexcom Inc (DXCM) is 61.80 USD. This relative valuation is based on P/E multiples. With the latest stock price at 84.51 USD, the upside of Dexcom Inc based on Relative Valuation is -26.9%.
The range of the Relative Valuation is 44.36 - 84.26 USD.
| Range | Selected | |
| Trailing P/E multiples | 32.5x - 45.8x | 37.4x |
| Forward P/E multiples | 32.4x - 46.0x | 39.6x |
| Fair Price | 44.36 - 84.26 | 61.80 |
| Upside | -47.5% - -0.3% | -26.9% |
| Date | P/E |
| 2025-05-23 | 61.92 |
| 2025-05-22 | 62.15 |
| 2025-05-21 | 62.19 |
| 2025-05-20 | 63.99 |
| 2025-05-19 | 63.71 |
| 2025-05-16 | 62.63 |
| 2025-05-15 | 62.77 |
| 2025-05-14 | 63.39 |
| 2025-05-13 | 61.62 |
| 2025-05-12 | 62.31 |
| 2025-05-09 | 62.03 |
| 2025-05-08 | 62.52 |
| 2025-05-07 | 61.07 |
| 2025-05-06 | 59.73 |
| 2025-05-05 | 58.81 |
| 2025-05-02 | 59.80 |
| 2025-05-01 | 51.48 |
| 2025-04-30 | 52.30 |
| 2025-04-29 | 52.24 |
| 2025-04-28 | 52.15 |
| 2025-04-25 | 52.50 |
| 2025-04-24 | 51.86 |
| 2025-04-23 | 48.98 |
| 2025-04-22 | 48.60 |
| 2025-04-21 | 48.43 |
| 2025-04-17 | 50.24 |
| 2025-04-16 | 50.35 |
| 2025-04-15 | 50.72 |
| 2025-04-14 | 49.37 |
| 2025-04-11 | 48.46 |
| 2025-04-10 | 49.31 |
| 2025-04-09 | 48.97 |
| 2025-04-08 | 44.46 |
| 2025-04-07 | 45.15 |
| 2025-04-04 | 43.83 |
| 2025-04-03 | 45.28 |
| 2025-04-02 | 49.92 |
| 2025-04-01 | 49.32 |
| 2025-03-31 | 50.03 |
| 2025-03-28 | 49.63 |
| 2025-03-27 | 50.90 |
| 2025-03-26 | 52.85 |
| 2025-03-25 | 53.89 |
| 2025-03-24 | 55.18 |
| 2025-03-21 | 54.07 |
| 2025-03-20 | 55.03 |
| 2025-03-19 | 53.76 |
| 2025-03-18 | 51.80 |
| 2025-03-17 | 52.27 |
| 2025-03-14 | 51.79 |